FDA
approval
· 2017-04-20
FDA Approved: VIBERZI — Supplemental Application (Allergan, Inc.)
Summary
FDA approved Allergan's supplemental application for VIBERZI (eluxadoline). This action approves changes requested in the supplement.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VIBERZI (ELUXADOLINE)